Pharvaris NV (PHVS)
38.17
+0.43
(+1.14%)
USD |
NASDAQ |
Sep 10, 12:50
Pharvaris Total Liabilities (Quarterly) : 31.85M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.85M |
| March 31, 2026 | 27.03M |
| December 31, 2025 | 35.45M |
| September 30, 2025 | 31.32M |
| June 30, 2025 | 29.90M |
| March 31, 2025 | 24.55M |
| December 31, 2024 | 24.45M |
| September 30, 2024 | 18.29M |
| June 30, 2024 | 20.45M |
| March 31, 2024 | 19.90M |
| December 31, 2023 | 16.18M |
| September 30, 2023 | 17.16M |
| June 30, 2023 | 17.47M |
| March 31, 2023 | 20.27M |
| Date | Value |
|---|---|
| December 31, 2022 | 19.72M |
| September 30, 2022 | 17.45M |
| June 30, 2022 | 16.90M |
| March 31, 2022 | 11.40M |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 6.502M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 2.160M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novartis AG | 80.09B |
| BioAge Labs, Inc. | 22.02M |
| AstraZeneca PLC | 66.63B |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 375.77M |
| Shareholders Equity (Quarterly) | 343.92M |
| Debt to Equity Ratio | 0.0022 |
| Current Ratio | 11.94 |
| Net Debt Paydown Yield | 0.00% |